Research Topics
| Kari JohansenSummaryAffiliation: Swedish Institute for Infectious Disease Control Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvantsKari Johansen
Department of Virology, Swedish Institute for Infectious Disease Control, Karolinska Institute, S 171 82, Solna, Sweden
Vaccine 21:368-75. 2003..E.M.+/-10750). All offsprings to immunized dams were protected against clinical diarrhea upon oral challenge with RRV. The IgG1/IgG2a ratio was in all immunized groups approximately 1 suggesting development of a balanced Th1/Th2 response...
Complications attributable to rotavirus-induced diarrhoea in a Swedish paediatric population: report from an 11-year surveillanceKari Johansen
Department of Virology, Swedish Institute for Infectious Disease Control, Solna, Sweden
Scand J Infect Dis 40:958-64. 2008..05). Interestingly, the age of children developing seizures and signs of encephalitis was significantly higher than in children with no complications (p<0.01)...- [Rotavirus vaccine can reduce the burden of illness. Decision on inclusion in the child vaccination program needs more data]Kari Johansen
Smittskyddsinstitutet, Stockholm
Lakartidningen 105:1169. 2008 - Norovirus strains belonging to the GII.4 genotype dominate as a cause of nosocomial outbreaks of viral gastroenteritis in Sweden 1997--2005. Arrival of new variants is associated with large nation-wide epidemicsKari Johansen
Department of Virology, Immunology and Vaccinology, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden
J Clin Virol 42:129-34. 2008..In recent years an increase of the incidence of nosocomial outbreaks caused by noroviruses has been observed throughout Sweden, with high peaks noted in the winter seasons 2002/2003 and 2004/2005, respectively... - Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrheaNeha Pant
Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
Future Microbiol 6:583-93. 2011..Using genetically engineered lactobacilli, producing high avidity llama VHH domains (referred to as anti-rotavirus proteins; ARPs), to test the effect of multimeric antibody fragments as prophylaxis and therapy against rotavirus infection... - Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmesMaria Kakoulidou
Department of Virology, Swedish Institute for Infectious Disease Control, Solna, Sweden
Vaccine 28:1002-7. 2010.... - Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrheaNeha Pant
Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska Huddinge, Stockholm, Sweden
J Infect Dis 194:1580-8. 2006..CONCLUSIONS: Transformed lactobacilli may form the basis of a novel form of prophylactic treatment against rotavirus infections and other diarrheal diseases... 
Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotypeMikael Nilsson
Department of Virology, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden
J Virol 77:13117-24. 2003....- Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvantAndreas Brave
Swedish Institute for Infectious Disease Control and Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden
Vaccine 26:5957-66. 2008..These data show that HIV-1 DNA-plasmid immunization during breast-feeding and recombinant protein boosting shortly thereafter enhance the breadth of humoral HIV-1-specific immune responses... - Kinetics of antibody and memory B cell responses after MMR immunization in children and young adultsMaria Kakoulidou
Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
Vaccine 31:711-7. 2013..It remains to be shown if memory B-cells provide the same protection as specific antibodies, but our data is a valuable complement to the incomplete knowledge about correlates of protection after vaccination... - [Rubella still a problem in Europe--important that pregnant women have an adequate protection]Kari Johansen
Klinisk virologi och pediatrik, , Smittskyddsinstitutet, Solna
Lakartidningen 101:3994-6, 3998-9. 2004 - Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in miceClaudia Istrate
Instituto de Biologia Experimental e Tecnologica and Instituto de Tecnologia Quimica e Biologica, SE 171 76 Oeiras, Portugal
Vaccine 26:4594-601. 2008..Passive protective immunity was achieved in offspring to dams vaccinated with 2 and 20 microg RV-VLPs in presence of adjuvant and 20 microg RV-VLP without adjuvant... - Rotavirus vaccines: considerations for successful implementation in EuropePierre Van Damme
Centre for the Evaluation of Vaccination, University of Antwerp, Belgium
Lancet Infect Dis 6:805-12. 2006..Further studies on the cost of the disease and the benefit of vaccination, together with raising awareness are necessary steps to ensure successful implementation of rotavirus vaccination in Europe... - Identification of viral agents associated with diarrhea in young children during a winter season in Beijing, ChinaChunyan Liu
Virology Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital Affiliated to Capital University of Medical Sciences, Beijing, China
J Clin Virol 35:69-72. 2006..A combination of microscopic examination of stool samples with specific EIA assays to detect virus antigen in stool specimens may be suitable for routine diagnostics... - Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targetsAnthony Nardone
Centre for Infections, Health Protection Agency, London, England
Bull World Health Organ 86:118-25. 2008..To standardize serological surveillance to compare rubella susceptibility in Australia and 16 European countries, and measure progress towards international disease-control targets... - Passive immunity against measles in infants: is there a need for policy changes in the European vaccination schedules?Kari Johansen
Euro Surveill 12:E3-4. 2007 - Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblastsIyadh Douagi
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Box 280, S 171 77 Stockholm, Sweden
J Virol 81:2758-68. 2007..However, in contrast to MEFs, this action was not sufficient to completely abrogate type I IFN induction, consistent with a role for DCs as sentinels for virus infection... - European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virusFernando de Ory
Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
J Clin Virol 36:111-8. 2006..The aim of the European Sero-Epidemiology Network (ESEN2) is to harmonise the serological surveillance of vaccine-preventable diseases in Europe... - High genetic diversity of measles virus, World Health Organization European Region, 2005-2006Jacques R Kremer
World Health Organization WHO Regional Reference Laboratory for Measles and Rubella, Laboratoire National de Santé Immunology 20A, rue Auguste Lumiere, Luxembourg, Luxembourg
Emerg Infect Dis 14:107-14. 2008..Thus, despite the reduction of endemic MV circulation, importation of MV from other continents caused prolonged circulation and large outbreaks after their introduction into unvaccinated and highly mobile communities...